Charles Schwab Investment Management Inc. Has $203,000 Stock Holdings in Waldencast plc (NASDAQ:WALD)

Charles Schwab Investment Management Inc. lessened its stake in shares of Waldencast plc (NASDAQ:WALDFree Report) by 11.8% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 55,765 shares of the company’s stock after selling 7,437 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Waldencast were worth $203,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of WALD. Milestones Administradora de Recursos Ltda. raised its holdings in Waldencast by 10.0% in the 3rd quarter. Milestones Administradora de Recursos Ltda. now owns 2,200,000 shares of the company’s stock valued at $8,008,000 after acquiring an additional 200,000 shares during the period. Renaissance Technologies LLC acquired a new position in shares of Waldencast in the second quarter valued at approximately $239,000. Simplicity Wealth LLC grew its position in shares of Waldencast by 416.2% in the third quarter. Simplicity Wealth LLC now owns 77,080 shares of the company’s stock valued at $281,000 after purchasing an additional 62,148 shares during the last quarter. Cubist Systematic Strategies LLC bought a new position in shares of Waldencast during the second quarter worth approximately $85,000. Finally, McAdam LLC acquired a new stake in Waldencast during the 3rd quarter worth approximately $62,000. Institutional investors and hedge funds own 41.97% of the company’s stock.

Waldencast Trading Up 2.5 %

WALD stock opened at $3.62 on Friday. Waldencast plc has a 52 week low of $2.40 and a 52 week high of $12.00. The business has a 50-day simple moving average of $3.45 and a 200 day simple moving average of $3.52. The company has a quick ratio of 0.78, a current ratio of 1.47 and a debt-to-equity ratio of 0.21.

Analyst Ratings Changes

A number of brokerages have commented on WALD. DA Davidson upped their price objective on Waldencast from $7.25 to $7.50 and gave the company a “buy” rating in a report on Wednesday, December 4th. Telsey Advisory Group restated an “outperform” rating and issued a $6.00 price target on shares of Waldencast in a research note on Monday, November 18th. TD Cowen began coverage on shares of Waldencast in a research report on Monday. They set a “hold” rating and a $4.30 price target on the stock. Canaccord Genuity Group initiated coverage on shares of Waldencast in a report on Friday, October 25th. They issued a “buy” rating and a $5.00 price objective for the company. Finally, Canaccord Genuity Group raised their target price on shares of Waldencast from $5.00 to $6.00 and gave the stock a “buy” rating in a report on Friday, November 22nd. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $5.76.

Get Our Latest Research Report on Waldencast

Waldencast Company Profile

(Free Report)

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.

Featured Articles

Want to see what other hedge funds are holding WALD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waldencast plc (NASDAQ:WALDFree Report).

Institutional Ownership by Quarter for Waldencast (NASDAQ:WALD)

Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.